Haichuan Hu

机构：Sir Run Run Shaw Hospital, Zhejiang University · ORCID：0000-0003-3436-290X

发表论文 150 篇 · 总被引 5578 次 · h-index 35

代表论文

• Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial (2025 · Journal of Clinical Oncology · 被引 30)
• Mapping utilizable rooftop areas to meet food security goal in four high-density cities: A deep learning and GIS integrated approach (2024 · Sustainable Cities and Society · 被引 20)
• IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer (2025 · Future Oncology · 被引 9)
• Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data (2024 · Translational Lung Cancer Research · 被引 8)
• Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment (2024 · Frontiers in Molecular Biosciences · 被引 4)
• Computational prediction of CNP0387675 as a non-nucleoside inhibitor of MraY, from natural product-based multi-template screening against Pseudomonas aeruginosa (2025 · Frontiers in Microbiology · 被引 2)